For informational purposes only — not investment advice

← Back to signals

MS

LONGINSIDER SELL

MORGAN STANLEY

Research: Finviz ↗·Perplexity ↗

Funds
3
Score
2.40
vs SPY
-0.3%
Stock return (since Q-end)
-6.4%
SPY return (since Q-end)
-6.1%
Current price
$174.98
Days to cover (short int.)
2.4d↑+4.9%
as of 2026-10-30 · shares short vs 2026-09-30

News Summary

Neutral

Morgan Stanley beat Q3 earnings estimates with $3.03 EPS (vs. $2.91 est.) and $20.3B revenue, driven by strong equities trading (+41% YoY) and record wealth management results ($8.43T AUM, +19.5% YoY). However, the stock declined 3% post-earnings amid analyst caution, and the firm faces a Delaware lawsuit alleging years of lax anti-money laundering oversight by current and former directors.

Red flags

  • •Delaware Chancery Court lawsuit alleging failure to oversee AML controls for years, involving former CEO Gorman
  • •Stock declined 3% despite earnings beat; Wells Fargo analyst called results 'good, not great'
  • •Data breach settlement ($6.5M) over compromised customer personal information
  • •Erste Group downgraded MS from 'buy' to 'hold' on October 8

Funds Buying (3)

FundManagerShares Held∆ SharesPosition Value% of FundQoQStatus
Viking GlobalAndreas Halvorsen1.9M+313K$364M1.1%+19%Existing
Point72Steve Cohen1.1M+867K$209M0.3%+353%Existing
Maverick CapitalLee Ainslie12K+12K$2M<0.1%—NEW

Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.

Portfolio Context

Where MS ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.

Viking Global

position #37 of this fund's book

  1. 34BIOMARIN PHARMACEUTICAL INC$430M
  2. 35FEDEX FGHT HLDG CO INC$424M
  3. 36GENUINE PARTS CO$376M
  4. 37MORGAN STANLEY$364M
  5. 38ZEBRA TECHNOLOGIES CORPORATI$355M
  6. 39EQUITABLE HLDGS INC$348M
  7. 40AGILENT TECHNOLOGIES INC$302M

Values are quarter-end position sizes. Shown only for funds where MS ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.

Insider Activity

NameTitleTypeSharesPriceValueFiledSrc
Miscik Judith A—SELL2K$183.21$0.45M2026-11-06↗

Congressional Trading

No trades dated since Jul 1, 2026.

Earlier trades (1) — dated outside this quarter's window, not counted in the badges
MemberChamberStateTypeAmount RangeTransaction DateFiledSrc
Alan Armstrongsenate—BUY$1,001 - $15,0002026-03-272026-07-21↗

Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures. Members often file weeks or months after trading, so trades are placed by transaction date: the badges above count trades dated since Jul 1, 2026.